Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Neuroprotective effects of riluzole in neurotrauma models: a review.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Rectus abdominis muscle endometriotic mass in a woman affected by multiple sclerosis.
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.
Solodyn
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
Plasma exchange in severe attacks of neuromyelitis optica.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Biologics at Novartis
Genzyme receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) application
Pages
« first
‹ previous
…
161
162
163
164
165
166
167
168
169
…
next ›
last »